![]() |
|
|
Vol. 17, Issue 12, 4962-4971, December 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


*Department of Biochemistry and Molecular Biology, Oregon Health & Sciences University, Portland, OR 97201; and
Vaccine and Gene Therapy Institute, Oregon Health & Sciences University, Beaverton, OR 97006-3448
Submitted April 17, 2006;
Revised August 14, 2006;
Accepted September 13, 2006
Monitoring Editor: Thomas Sommer
Proteolytic activity of the 20S proteasome is regulated by activators that govern substrate movement into and out of the catalytic chamber. However, the physiological relationship between activators, and hence the relative role of different proteasome species, remains poorly understood. To address this problem, we characterized the total pool of cytosolic proteasomes in intact and functional form using a single-step method that bypasses the need for antibodies, proteasome modification, or column purification. Two-dimensional Blue Native(BN)/SDS-PAGE and tandem mass spectrometry simultaneously identified six native proteasome populations in untreated cytosol: 20S, singly and doubly PA28-capped, singly 19S-capped, hybrid, and doubly 19S-capped proteasomes. All proteasome species were highly dynamic as evidenced by recruitment and exchange of regulatory caps. In particular, proteasome inhibition with MG132 markedly stimulated PA28 binding to exposed 20S
-subunits and generated doubly PA28-capped and hybrid proteasomes. PA28 recruitment virtually eliminated free 20S particles and was blocked by ATP depletion. Moreover, inhibited proteasomes remained stably associated with distinct cohorts of partially degraded fragments derived from cytosolic and ER substrates. These data establish a versatile platform for analyzing substrate-specific proteasome function and indicate that PA28 and 19S activators cooperatively regulate global protein turnover while functioning at different stages of the degradation cycle.
Address correspondence to: William R. Skach (skachw{at}ohsu.edu)
Abbreviations used: 19S RC, 19S regulatory subunit; ER, endoplasmic reticulum; PA28, proteasome activator, 28 kDa; RRL, rabbit reticulocyte lysate; BN-PAGE, blue native-polyacrylamide gel electrophoresis.
This article has been cited by other articles:
![]() |
S. R. Powell and A. Divald The ubiquitin-proteasome system in myocardial ischaemia and preconditioning Cardiovasc Res, January 15, 2010; 85(2): 303 - 311. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-P. Bousquet-Dubouch, E. Baudelet, F. Guerin, M. Matondo, S. Uttenweiler-Joseph, O. Burlet-Schiltz, and B. Monsarrat Affinity Purification Strategy to Capture Human Endogenous Proteasome Complexes Diversity and to Identify Proteasome-interacting Proteins Mol. Cell. Proteomics, May 1, 2009; 8(5): 1150 - 1164. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Rousseau, R. Kojima, G. Hoffner, P. Djian, and A. Bertolotti Misfolding of Proteins with a Polyglutamine Expansion Is Facilitated by Proteasomal Chaperones J. Biol. Chem., January 16, 2009; 284(3): 1917 - 1929. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ge, Y. Luo, C. L. Liu, and B. Hu Protein Aggregation and Proteasome Dysfunction After Brain Ischemia Stroke, December 1, 2007; 38(12): 3230 - 3236. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Herrmann, L. O. Lerman, and A. Lerman Ubiquitin and Ubiquitin-Like Proteins in Protein Regulation Circ. Res., May 11, 2007; 100(9): 1276 - 1291. [Abstract] [Full Text] [PDF] |
||||